The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glycobiology & Glycomics-Global Market Insights and Sales Trends 2025
Synopsis
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The global Glycobiology & Glycomics market size is expected to reach US$ 1421.7 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Glycobiology & Glycomics in various end use industries. The expanding demands from the Oncology, Diagnostics, Immunology and Drug Discovery and Development, are propelling Glycobiology & Glycomics market. Eagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymes segment is estimated at % CAGR for the next seven-year period.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 34%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycobiology & Glycomics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycobiology & Glycomics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycobiology & Glycomics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycobiology & Glycomics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycobiology & Glycomics covered in this report include Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Waters Corp, Bruker Corp, Sigma-Aldrich Corp, Takara Bio, Prozyme and Danaher Corp, etc.
The global Glycobiology & Glycomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Agilent Technologies
New England Biolabs
Waters Corp
Bruker Corp
Sigma-Aldrich Corp
Takara Bio
Prozyme
Danaher Corp
Shimadzu Corp
Global Glycobiology & Glycomics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycobiology & Glycomics market, Segment by Type:
Eagents
Enzymes
Kits
Instruments
Global Glycobiology & Glycomics market, by Application
Oncology
Diagnostics
Immunology
Drug Discovery and Development
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glycobiology & Glycomics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glycobiology & Glycomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The global Glycobiology & Glycomics market size is expected to reach US$ 1421.7 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Glycobiology & Glycomics in various end use industries. The expanding demands from the Oncology, Diagnostics, Immunology and Drug Discovery and Development, are propelling Glycobiology & Glycomics market. Eagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymes segment is estimated at % CAGR for the next seven-year period.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 34%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycobiology & Glycomics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycobiology & Glycomics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycobiology & Glycomics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycobiology & Glycomics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycobiology & Glycomics covered in this report include Thermo Fisher Scientific, Agilent Technologies, New England Biolabs, Waters Corp, Bruker Corp, Sigma-Aldrich Corp, Takara Bio, Prozyme and Danaher Corp, etc.
The global Glycobiology & Glycomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Agilent Technologies
New England Biolabs
Waters Corp
Bruker Corp
Sigma-Aldrich Corp
Takara Bio
Prozyme
Danaher Corp
Shimadzu Corp
Global Glycobiology & Glycomics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycobiology & Glycomics market, Segment by Type:
Eagents
Enzymes
Kits
Instruments
Global Glycobiology & Glycomics market, by Application
Oncology
Diagnostics
Immunology
Drug Discovery and Development
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glycobiology & Glycomics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glycobiology & Glycomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Glycobiology & Glycomics Market Overview
1.1 Glycobiology & Glycomics Product Overview
1.2 Glycobiology & Glycomics Market Segment by Type
1.2.1 Eagents
1.2.2 Enzymes
1.2.3 Kits
1.2.4 Instruments
1.3 Global Glycobiology & Glycomics Market Size by Type
1.3.1 Global Glycobiology & Glycomics Market Size Overview by Type (2018-2029)
1.3.2 Global Glycobiology & Glycomics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Glycobiology & Glycomics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glycobiology & Glycomics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Glycobiology & Glycomics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Glycobiology & Glycomics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Glycobiology & Glycomics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Glycobiology & Glycomics Sales Breakdown by Type (2018-2023)
2 Global Glycobiology & Glycomics Market Competition by Company
2.1 Global Top Players by Glycobiology & Glycomics Sales (2018-2023)
2.2 Global Top Players by Glycobiology & Glycomics Revenue (2018-2023)
2.3 Global Top Players by Glycobiology & Glycomics Price (2018-2023)
2.4 Global Top Manufacturers Glycobiology & Glycomics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glycobiology & Glycomics Market Competitive Situation and Trends
2.5.1 Glycobiology & Glycomics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Glycobiology & Glycomics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glycobiology & Glycomics as of 2022)
2.7 Date of Key Manufacturers Enter into Glycobiology & Glycomics Market
2.8 Key Manufacturers Glycobiology & Glycomics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glycobiology & Glycomics Status and Outlook by Region
3.1 Global Glycobiology & Glycomics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Glycobiology & Glycomics Historic Market Size by Region
3.2.1 Global Glycobiology & Glycomics Sales in Volume by Region (2018-2023)
3.2.2 Global Glycobiology & Glycomics Sales in Value by Region (2018-2023)
3.2.3 Global Glycobiology & Glycomics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Glycobiology & Glycomics Forecasted Market Size by Region
3.3.1 Global Glycobiology & Glycomics Sales in Volume by Region (2024-2029)
3.3.2 Global Glycobiology & Glycomics Sales in Value by Region (2024-2029)
3.3.3 Global Glycobiology & Glycomics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Glycobiology & Glycomics by Application
4.1 Glycobiology & Glycomics Market Segment by Application
4.1.1 Oncology
4.1.2 Diagnostics
4.1.3 Immunology
4.1.4 Drug Discovery and Development
4.1.5 Others
4.2 Global Glycobiology & Glycomics Market Size by Application
4.2.1 Global Glycobiology & Glycomics Market Size Overview by Application (2018-2029)
4.2.2 Global Glycobiology & Glycomics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Glycobiology & Glycomics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glycobiology & Glycomics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Glycobiology & Glycomics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Glycobiology & Glycomics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Glycobiology & Glycomics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Glycobiology & Glycomics Sales Breakdown by Application (2018-2023)
5 North America Glycobiology & Glycomics by Country
5.1 North America Glycobiology & Glycomics Historic Market Size by Country
5.1.1 North America Glycobiology & Glycomics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Glycobiology & Glycomics Sales in Volume by Country (2018-2023)
5.1.3 North America Glycobiology & Glycomics Sales in Value by Country (2018-2023)
5.2 North America Glycobiology & Glycomics Forecasted Market Size by Country
5.2.1 North America Glycobiology & Glycomics Sales in Volume by Country (2024-2029)
5.2.2 North America Glycobiology & Glycomics Sales in Value by Country (2024-2029)
6 Europe Glycobiology & Glycomics by Country
6.1 Europe Glycobiology & Glycomics Historic Market Size by Country
6.1.1 Europe Glycobiology & Glycomics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Glycobiology & Glycomics Sales in Volume by Country (2018-2023)
6.1.3 Europe Glycobiology & Glycomics Sales in Value by Country (2018-2023)
6.2 Europe Glycobiology & Glycomics Forecasted Market Size by Country
6.2.1 Europe Glycobiology & Glycomics Sales in Volume by Country (2024-2029)
6.2.2 Europe Glycobiology & Glycomics Sales in Value by Country (2024-2029)
7 Asia-Pacific Glycobiology & Glycomics by Region
7.1 Asia-Pacific Glycobiology & Glycomics Historic Market Size by Region
7.1.1 Asia-Pacific Glycobiology & Glycomics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Glycobiology & Glycomics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Glycobiology & Glycomics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Glycobiology & Glycomics Forecasted Market Size by Region
7.2.1 Asia-Pacific Glycobiology & Glycomics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Glycobiology & Glycomics Sales in Value by Region (2024-2029)
8 Latin America Glycobiology & Glycomics by Country
8.1 Latin America Glycobiology & Glycomics Historic Market Size by Country
8.1.1 Latin America Glycobiology & Glycomics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Glycobiology & Glycomics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Glycobiology & Glycomics Sales in Value by Country (2018-2023)
8.2 Latin America Glycobiology & Glycomics Forecasted Market Size by Country
8.2.1 Latin America Glycobiology & Glycomics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Glycobiology & Glycomics Sales in Value by Country (2024-2029)
9 Middle East and Africa Glycobiology & Glycomics by Country
9.1 Middle East and Africa Glycobiology & Glycomics Historic Market Size by Country
9.1.1 Middle East and Africa Glycobiology & Glycomics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Glycobiology & Glycomics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Glycobiology & Glycomics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Glycobiology & Glycomics Forecasted Market Size by Country
9.2.1 Middle East and Africa Glycobiology & Glycomics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Glycobiology & Glycomics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Company Information
10.1.2 Thermo Fisher Scientific Introduction and Business Overview
10.1.3 Thermo Fisher Scientific Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific Glycobiology & Glycomics Products Offered
10.1.5 Thermo Fisher Scientific Recent Development
10.2 Agilent Technologies
10.2.1 Agilent Technologies Company Information
10.2.2 Agilent Technologies Introduction and Business Overview
10.2.3 Agilent Technologies Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Agilent Technologies Glycobiology & Glycomics Products Offered
10.2.5 Agilent Technologies Recent Development
10.3 New England Biolabs
10.3.1 New England Biolabs Company Information
10.3.2 New England Biolabs Introduction and Business Overview
10.3.3 New England Biolabs Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 New England Biolabs Glycobiology & Glycomics Products Offered
10.3.5 New England Biolabs Recent Development
10.4 Waters Corp
10.4.1 Waters Corp Company Information
10.4.2 Waters Corp Introduction and Business Overview
10.4.3 Waters Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Waters Corp Glycobiology & Glycomics Products Offered
10.4.5 Waters Corp Recent Development
10.5 Bruker Corp
10.5.1 Bruker Corp Company Information
10.5.2 Bruker Corp Introduction and Business Overview
10.5.3 Bruker Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bruker Corp Glycobiology & Glycomics Products Offered
10.5.5 Bruker Corp Recent Development
10.6 Sigma-Aldrich Corp
10.6.1 Sigma-Aldrich Corp Company Information
10.6.2 Sigma-Aldrich Corp Introduction and Business Overview
10.6.3 Sigma-Aldrich Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sigma-Aldrich Corp Glycobiology & Glycomics Products Offered
10.6.5 Sigma-Aldrich Corp Recent Development
10.7 Takara Bio
10.7.1 Takara Bio Company Information
10.7.2 Takara Bio Introduction and Business Overview
10.7.3 Takara Bio Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takara Bio Glycobiology & Glycomics Products Offered
10.7.5 Takara Bio Recent Development
10.8 Prozyme
10.8.1 Prozyme Company Information
10.8.2 Prozyme Introduction and Business Overview
10.8.3 Prozyme Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Prozyme Glycobiology & Glycomics Products Offered
10.8.5 Prozyme Recent Development
10.9 Danaher Corp
10.9.1 Danaher Corp Company Information
10.9.2 Danaher Corp Introduction and Business Overview
10.9.3 Danaher Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Danaher Corp Glycobiology & Glycomics Products Offered
10.9.5 Danaher Corp Recent Development
10.10 Shimadzu Corp
10.10.1 Shimadzu Corp Company Information
10.10.2 Shimadzu Corp Introduction and Business Overview
10.10.3 Shimadzu Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Shimadzu Corp Glycobiology & Glycomics Products Offered
10.10.5 Shimadzu Corp Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glycobiology & Glycomics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glycobiology & Glycomics Industrial Chain Analysis
11.4 Glycobiology & Glycomics Market Dynamics
11.4.1 Glycobiology & Glycomics Industry Trends
11.4.2 Glycobiology & Glycomics Market Drivers
11.4.3 Glycobiology & Glycomics Market Challenges
11.4.4 Glycobiology & Glycomics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glycobiology & Glycomics Distributors
12.3 Glycobiology & Glycomics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
